Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Angioplasty Balloons Companies

ID: MRFR/HC/8136-HCR
200 Pages
Rahul Gotadki
Last Updated: February 16, 2025
Angioplasty balloons are medical devices used in the treatment of coronary artery disease and peripheral artery disease. These balloons are inserted into narrowed or blocked blood vessels and inflated to open the vessel and improve blood flow.
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Angioplasty Balloons Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)3.81%
2024 Market Size$ 3.38 Billion
2025 Market Size$ 3.51 Billion
2035 Market Size$ 5.1 Billion
Key Players
Boston Scientific
Medtronic
Abbott Laboratories
B. Braun Melsungen AG
Cordis
Terumo Corporation
Opportunities
  • Regulatory Influence on Market Dynamics
  • Rising Prevalence of Cardiovascular Diseases
  • Growing Investment in Healthcare Infrastructure

Top Industry Leaders in the Angioplasty Balloons Market

Angioplasty Balloons Key Companies
 
Latest Angioplasty Balloons Companies Update:

Boston Scientific Corporation Received FDA approval for the Veritas™ Prime Plus Balloon Catheter in July 2023, featuring a low-profile design and enhanced pushability for complex lesions.

Medtronic Launched the Resolute Onyx™ Drug-Eluting Balloon in October 2023, offering sustained drug release and improved lesion coverage for long-term vessel patency.

Abbott Laboratories Partnered with a biomaterials company in November 2023 to develop novel balloon coatings with anti-inflammatory properties, aiming to reduce post-procedure complications.

Trivascular Introduced the Typhoon™ Catheter with TriMax Technology in December 2023, combining a balloon with distal protection and embolic filtration capabilities for improved procedural safety.

Cook Medical Expanded its portfolio with the BioFreedom™ Bioresorbable Stent in February 2024, offering a fully absorbable option for temporary vessel support after angioplasty.

List of Angioplasty Balloons Key companies in the market
  • Abbott (US)
  • Braun Melsungen AG (Germany)
  • R. Bard (BD) (US)
  • Biotronik SE & Co. KG (Germany)
  • Boston Scientific Corporation (US)
  • Cordis (Cardinal Health) (US)
  • Cook (US)
  • Koninklijke Philips N.V. (Netherlands)
  • Medtronic (Ireland)
  • Terumo Medical Corporation (Japan)
  • Endocor (Germany)